Home › Major Depressive Disorder › NCT06110897
RESISTance Exercise for Depression Trial
Resistance Exercise to Treat Major Depression Via Cerebrovascular Mechanisms: Confirming Efficacy and Informing Precision Medicine
Who can join
Ages 18 to 65 · All sexes
Full eligibility criteria
Inclusion Criteria:
* Be diagnosed with DSM-5 MDD, confirmed via Structured Clinical Interview for DSM-5 (SCID).
* Have current depressive symptoms of at least mild severity defined by the Hamilton Rating Scale of Depression 17 greater than or equal to 8 (HAMD; using the GRID-HAMD evaluated by trained, masked raters)
* Be ages 18-65
* EITHER not taking any mental health medications or seeking other mental health treatment (e.g., behavioral, psychological) OR be on a stable mental health medication and/or treatment regimen for the past 8 weeks, and intend to maintain that regimen for the duration of the study
* Safe to exercise based on physical activity screening questions or physician clearance
* Willing to be randomized to either condition
* have a Smartphone
Exclusion Criteria:
* Currently pregnant, nursing, or planning to become pregnant during the trial
* Class III+ obesity
* Diagnosed with lifetime or current Psychosis, Mania, or Bipolar Disorder, via the SCID
* Diagnosed with current Substance Use Disorder, via the SCID
* Active suicidal ideation with specific plan and intent ('5' score on Suicidal Ideation from Columbia Suicide Severity Rating Scale), which would necessitate immediate emergent care
* Exhibit behavioral disturbance (e.g., aggression, mild-moderate cognitive impairment) that would significantly interfere with study participation, as assessed by clinical research personnel
* Currently meets resistance exercise recommendations (2 days per week) for the last 8 weeks
* Self-reporting a concussion/traumatic brain injury within the last 3 months
* Having cardiovascular disease, uncontrolled hypertension, or uncontrolled diabetesAbout the study
Depression is a leading cause of disability worldwide and current treatments are ineffective for many people. This trial will investigate the efficacy of a 16-week high vs low dose resistance exercise training program for the treatment of Major Depressive Disorder (MDD) in 200 adults.
What is being tested
- High Dose Resistance Exercise Training (behavioral)
- Low Dose Resistance Exercise Training Group (behavioral)
Sponsor: University of Wisconsin, Madison · Participants: 200 · Started: Jan 1, 2024
Contact the study team
- Taline Jouzi · Phone: 608-890-0154
Official record on ClinicalTrials.gov — NCT06110897
Locations in the U.S.
| Wisconsin | University of Wisconsin - Madison, Madison |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.